The RISE Forum: A Research, Innovation, & Science Exchange: Clinical Trials in Interventional Oncology (Part 2)

Moderators: 

• Jens Ricke, MD
• Philippe Pereira, MD

Faculty: 

• Jens Ricke, MD | Rational Design of IO-Immunotherapy Combinations
  • Learning Objectives:
    • Identify barriers to combinations specific to IO procedures (focus HCC and one other Ca if topic is to broad)
    • Describe technical considerations for trials in combination therapies

• Liliana Violante, MD | Theranostic Approaches: Combined Diagnostic and Radioembolization
  • Learning Objectives:
    • Discuss idea of next- generation radioembolization devices
    • Discuss whether there a future convergence between these different concepts

• Amy Deipolyi, MD, PhD, FSIR | Critical Gaps in Clinical Data: Looking Toward the Future
  • Learning Objectives:
    • Identify priorities for future IO trials
    • Identify short term (1-3 year), mid term (3-6 year), and long term (6-10 year) achievable goals for the IO community to engage with

• All Faculty | ROUNDTABLE DISCUSSION: Evolving Trial Evidence and Clinical Practice Changes
  • Learning Objectives:
    • How recent trial results should influence current treatment algorithms and future research directions